Alpine Immune Sciences (FRA:34LA) Accumulated other comprehensive income (loss) : €-0.24 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Alpine Immune Sciences Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Alpine Immune Sciences's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-0.24 Mil.

Alpine Immune Sciences's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-0.51 Mil) to Dec. 2023 (€0.36 Mil) but then declined from Dec. 2023 (€0.36 Mil) to Mar. 2024 (€-0.24 Mil).

Alpine Immune Sciences's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-0.24 Mil) to Dec. 2022 (€-1.06 Mil) but then increased from Dec. 2022 (€-1.06 Mil) to Dec. 2023 (€0.36 Mil).

Alpine Immune Sciences Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Alpine Immune Sciences's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpine Immune Sciences Accumulated other comprehensive income (loss) Chart

Alpine Immune Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

0.01

0.04

-0.24

-1.06

0.36

Alpine Immune Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-0.38	-0.60	-0.51	0.36	-0.24

Alpine Immune Sciences Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Alpine Immune Sciences Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Alpine Immune Sciences's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpine Immune Sciences (FRA:34LA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpine Immune Sciences Inc (FRA:34LA) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

ALPN:USA 34LA:Germany

Address

188 East Blaine Street, Suite 200, Seattle, WA, USA, 98102

Website

https://www.alpineimmunesciences.com

Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company dedicated to discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its pipeline candidates are; ALPN-303, or povetacicept, is a dual antagonist of the B cell activating factor, or BAFF, and a proliferation-inducing ligand, or APRIL, cytokines, which play key roles in the activation, development, and survival of B cells, and ALPN-101, or acazicolcept, is a dual Inducible T cell Costimulator, or ICOS, and CD28 antagonist intended for the treatment of autoimmune and inflammatory diseases.

Alpine Immune Sciences (FRA:34LA) Headlines

No Headlines